BIOMAT Database Logo BIOMAT Database Logo

Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. 1996

N F Marshall, and J Peng, and Z Xie, and D H Price
Department of Biochemistry, University of Iowa, Iowa City, Iowa 52242, USA.

The entry of RNA polymerase II into a productive mode of elongation is controlled, in part, by the postinitiation activity of positive transcription elongation factor b (P-TEFb) (Marshall, N. F., and Price, D. H. (1995) J. Biol. Chem. 270, 12335-12338). We report here that removal of the carboxyl-terminal domain (CTD) of the large subunit of RNA polymerase II abolishes productive elongation. Correspondingly, we found that P-TEFb can phosphorylate the CTD of pure RNA polymerase II. Furthermore, P-TEFb can phosphorylate the CTD of RNA polymerase II when the polymerase is in an early elongation complex. Both the function and kinase activity of P-TEFb are blocked by the drugs 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) and H-8. P-TEFb is distinct from transcription factor IIH (TFIIH) because the two factors have no subunits in common, P-TEFb is more sensitive to DRB than is TFIIH, and most importantly, TFIIH cannot substitute functionally for P-TEFb. We propose that phosphorylation of the CTD by P-TEFb controls the transition from abortive into productive elongation mode.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011494 Protein Kinases A family of enzymes that catalyze the conversion of ATP and a protein to ADP and a phosphoprotein. Protein Kinase,Kinase, Protein,Kinases, Protein
D006868 Hydrolysis The process of cleaving a chemical compound by the addition of a molecule of water.
D012319 RNA Polymerase II A DNA-dependent RNA polymerase present in bacterial, plant, and animal cells. It functions in the nucleoplasmic structure and transcribes DNA into RNA. It has different requirements for cations and salt than RNA polymerase I and is strongly inhibited by alpha-amanitin. EC 2.7.7.6. DNA-Dependent RNA Polymerase II,RNA Pol II,RNA Polymerase B,DNA Dependent RNA Polymerase II
D014157 Transcription Factors Endogenous substances, usually proteins, which are effective in the initiation, stimulation, or termination of the genetic transcription process. Transcription Factor,Factor, Transcription,Factors, Transcription
D051758 Transcription Factor TFIIH A general transcription factor that is involved in basal GENETIC TRANSCRIPTION and NUCLEOTIDE EXCISION REPAIR. It consists of nine subunits including ATP-DEPENDENT DNA HELICASES; CYCLIN H; and XERODERMA PIGMENTOSUM GROUP D PROTEIN. TFIIH Transcription Factor,BTF2 Transcription Factor,Basic Transcription Factor 2,Transcription Factor BTF2,Transcription Factor IIH,BTF2, Transcription Factor,TFIIH, Transcription Factor,Transcription Factor, BTF2,Transcription Factor, TFIIH
D019473 Transcription Factors, TFII The so-called general transcription factors that bind to RNA POLYMERASE II and that are required to initiate transcription. They include TFIIA; TFIIB; TFIID; TFIIE; TFIIF; TFIIH; TFII-I; and TFIIJ. In vivo they apparently bind in an ordered multi-step process and/or may form a large preinitiation complex called RNA polymerase II holoenzyme. TFII Transcription Factors

Related Publications

N F Marshall, and J Peng, and Z Xie, and D H Price
Yeast carboxyl-terminal domain kinase I positively and negatively regulates RNA polymerase II carboxyl-terminal domain phosphorylation.
September 1999, The Journal of biological chemistry,
N F Marshall, and J Peng, and Z Xie, and D H Price
CDK12 globally stimulates RNA polymerase II transcription elongation and carboxyl-terminal domain phosphorylation.
August 2020, Nucleic acids research,
N F Marshall, and J Peng, and Z Xie, and D H Price
Positive transcription elongation factor B phosphorylates hSPT5 and RNA polymerase II carboxyl-terminal domain independently of cyclin-dependent kinase-activating kinase.
April 2001, The Journal of biological chemistry,
N F Marshall, and J Peng, and Z Xie, and D H Price
Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.
October 2003, European journal of biochemistry,
N F Marshall, and J Peng, and Z Xie, and D H Price
Modulation of RNA polymerase II elongation efficiency by C-terminal heptapeptide repeat domain kinase I.
April 1997, The Journal of biological chemistry,
N F Marshall, and J Peng, and Z Xie, and D H Price
Dephosphorylation of the carboxyl-terminal domain of RNA polymerase II.
January 2003, Methods in enzymology,
N F Marshall, and J Peng, and Z Xie, and D H Price
Tyrosine phosphorylation of mammalian RNA polymerase II carboxyl-terminal domain.
December 1993, Proceedings of the National Academy of Sciences of the United States of America,
N F Marshall, and J Peng, and Z Xie, and D H Price
A carboxyl-terminal-domain kinase associated with RNA polymerase II transcription factor delta from rat liver.
August 1992, Proceedings of the National Academy of Sciences of the United States of America,
N F Marshall, and J Peng, and Z Xie, and D H Price
Direct evidence that HIV-1 Tat stimulates RNA polymerase II carboxyl-terminal domain hyperphosphorylation during transcriptional elongation.
July 1999, Journal of molecular biology,
N F Marshall, and J Peng, and Z Xie, and D H Price
Analysis of polymerase II elongation complexes by native gel electrophoresis. Evidence for a novel carboxyl-terminal domain-mediated termination mechanism.
May 2004, The Journal of biological chemistry,
Copied contents to your clipboard!